Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

India's National Viral Hepatitis Control Program (NVHCP) has screened more than 210.6 million people and treated over 612,000 patients as of March 2026, according to the Ministry of Health and Family Welfare ahead of World Hepatitis Day 2026.

Viral hepatitis remains a major public health challenge. The World Health Organization (WHO) estimates that hepatitis caused 1.34 million deaths globally in 2015, a toll comparable to tuberculosis. In India, an estimated 40 million people live with Hepatitis B, while 6-12 million have Hepatitis C.

According to the 2021 HIV Sentinel Surveillance:

• 0.85% tested positive for Hepatitis B
• 0.29% tested positive for Hepatitis C

This is roughly equivalent to 1 in 118 people testing positive for Hepatitis B and 1 in 345 for Hepatitis C among those surveyed.

India's Plan to Eliminate Hepatitis

Launched in 2018, the National Viral Hepatitis Control Program aims to:

• Eliminate Hepatitis C by 2030
• Reduce infections, illness and deaths caused by Hepatitis B and C
• Prevent complications such as cirrhosis and liver cancer
• Reduce the burden of Hepatitis A and E

"Since 2018, India's National Viral Hepatitis Control Program has offered free screening and treatment for Hepatitis B and C nationwide. Smart use of local funding, cheaper generic drugs, and existing health programs has helped expand this care further," the government said in an official statement.

"Services are now moving from district hospitals down to local health centers, bringing testing and treatment closer to everyone," it added.

How Does It Work?

• Covers Hepatitis A, B, C, D and E
• Free testing and medicines for Hepatitis B and C
• Digital patient monitoring through the NVHCP-MIS portal
• Focus on prevention, awareness, screening and treatment
• The NVHCP is integrated with several health programs to expand access to prevention and care.
• Universal screening of pregnant women for Hepatitis B
• Hepatitis B birth dose for every newborn
• HBIG for infants born to Hepatitis B-positive mothers within 24 hours
• Screening of high-risk groups for Hepatitis B and C
• Hepatitis B vaccination for healthcare workers and eligible high-risk groups
• Uses existing TB molecular testing machines for hepatitis diagnosis
• Refers Hepatitis B and C-positive blood donors for treatment

What Is Hepatitis?

Hepatitis is inflammation of the liver caused by viruses, alcohol, certain drugs, toxins, or autoimmune diseases. Hepatitis B and C are the most common causes of chronic liver disease and can lead to cirrhosis and liver cancer if left untreated.

World Hepatitis Day 2026

World Hepatitis Day is observed each year on 28 July to raise awareness of viral hepatitis.

The World Hepatitis Day 2026 theme, “Hepatitis: Let’s break it down,” is a call to remove the barriers that stand between people and the services that can save their lives. Viral hepatitis continues to be a major cause of preventable illness and death worldwide.

A new study suggests that when you eat may be just as important as what you eat to support brain health as you age.

Researchers have found that restricting food intake to an 8 to 9-hour window each day and avoiding food for at least four hours before bedtime may help reduce age-related cognitive decline, particularly among older adults living with overweight or obesity.

The findings were presented at the American Society for Nutrition's NUTRITION 2026 annual meeting. The study supports the notion that fixed mealtimes could support healthy ageing beyond weight loss.

What Did The Study Find?

Led by researchers at Rutgers University, the study is based on 47 women aged 50 to 79 years who were overweight or obese.

All participants were enrolled in a six-month weight-loss programme and asked to consume 500 fewer calories per day. They were then divided into two groups:

Time-restricted eating group: Ate all meals within an 8 to 9-hour window, typically between 10 am and 6 pm.

Control group: Spread meals across a more conventional 12-hour eating window.

Both groups lost around 6.8 to 7 kg over six months. However, participants who followed the shorter eating window performed significantly better on tests assessing spatial planning, problem-solving, and executive function.

Researchers also noticed that they also committed fewer memory and learning errors.

Why Could Meal Timing Matter?

Also read: Scientists Say Changes In Brain In Your 40s & 50s May Influence Dementia Risk

Following fixed meal times can regulate the body's circadian rhythm, the internal biological clock that keeps sleep in check, metabolism, hormone release, and other essential brain functions.

Eating earlier in the day and avoiding late-night meals may improve metabolic health, reduce inflammation, enhance insulin sensitivity, and support healthier brain function over time. These factors are known to lower risk of cognitive decline.

Lead investigator Professor Sue Shapses, nutritional scientist at Rutgers University and Rutgers-RWJ Medical Center, said, "Losing weight alone will ward off some of the aging-related cognitive decline, and these data suggest that there may be additional benefits if you stop eating four hours before going to sleep and reduce food intake to 8 to 9 hours per day, compared with the usual eating window of 12 hours per day."

She added, "These outcomes suggest a better ability to remember information during everyday tasks and reducing mistakes related to memory, attention and problem-solving. Reductions in the eating window predicted greater improvements."

Can It Influence Dementia Risk?

Also read: Japanese PM Sanae Takaichi Sleeps 3 Hours A Night: How Much Sleep Do You Really Need?

The researchers stress that the study does not prove that a 9-hour eating window prevents dementia. Instead, it suggests that meal timing could become one of several lifestyle strategies to support cognitive health.

Dementia risk is influenced by multiple factors including age, genetics, obesity, diabetes, hypertension, physical activity, sleep, and diet. Time-restricted eating may eventually become part of a broader prevention approach if future research confirms these findings.

Dementia Risk Gets Influenced During Midlife

A recent study found that brain undergoes immune changes during 40s and 50s that could influence the risk of dementia.

Researchers found that the hippocampus, the brain region responsible for learning and memory, experiences a major shift in its immune cells during the 40s and 50s.

Once this immune environment changes, it may make the brain more vulnerable to inflammation and cognitive decline.

The findings suggest that this change could lead to chronic inflammation associated with Alzheimer's disease and other forms of dementia in the future .

US President Donald Trump should take a month-long break for his health, friend Bill O'Reilly has suggested.

The American conservative political commentator and television host made the remarks during a recent episode of his show.

“I noticed that he’s hunching over a little bit,” said O'Reilly, noting that he has known Trump for 35 years and expressing concern about the 80-year-old president's health, TV Insider reported.

“That’s normal. You get older, every malady in the world is going to visit you. I can’t even bore you with the stuff I gotta deal with. I was actually feeling sorry for myself the other day and I never do that.”

Offering advice, O'Reilly said Trump should “take the next month off, if you can.” He urged the president to “get into an environment” he enjoys, suggesting he spend time playing golf and “relax a little bit.”

Renewed Scrutiny Over Trump's Health

Questions about Trump's health have resurfaced during his second term following a series of public appearances.

Observers have pointed to swollen ankles, bruising on his hands, verbal slips, and occasional moments in which he appeared drowsy during meetings and international summits. Some physicians have also publicly raised concerns about the president's physical and cognitive health, although none have diagnosed him with dementia.

Trump has repeatedly rejected suggestions that he is experiencing cognitive decline or other serious health problems. His latest annual physical examination concluded that he is "in excellent health."

Bruising and Rash Draw Online Attention

Recent photographs have shown discoloration on both of Trump's hands. His right hand has repeatedly drawn attention in recent months for bruising that often appeared to be covered with concealer, while newer images also showed discoloration on his left hand.

“Bruising and discoloration was visible today on Trump's left hand, which is not the one that is usually mangled,” independent journalist Aaron Rupar wrote on social media platform X.

Earlier this month, Trump was also photographed with a visible neck rash and a bruised right hand that appeared to be covered with makeup during the 2026 NATO Summit in Türkiye. The back of his right hand appeared noticeably darker than the surrounding skin, suggesting cosmetic coverage, The Independent reported.

Trump has also been unsteady on his feet on some occasions, particularly while using stairs.

White House Dismisses Concerns

The White House has repeatedly rejected concerns about Trump's health, attributing the bruising to the physical demands of his schedule.

"President Trump is the sharpest, most accessible, and energetic president in American history," White House spokesperson Davis Ingle said in a statement to The Independent.

In February, White House Press Secretary Karoline Leavitt similarly said the bruising was caused by frequent handshaking.

Following Trump's most recent medical examination in May, White House physician Dr. Sean Barbabella said the bruising was consistent with "minor soft tissue irritation related to frequent handshaking" while the president was taking aspirin as a preventive measure against cardiovascular disease.

After the check-up at Walter Reed, Trump wrote on Truth Social that "everything" had "checked out PERFECTLY."

The White House has also addressed concerns over swelling around Trump's ankles, saying it is caused by blood pooling in the lower legs—a common condition among older adults.